BIOMAT Database Logo BIOMAT Database Logo

In vitro antibacterial activity of aztreonam against gram-negative bacilli isolated in 1985. 1988

Y Miyake, and T Yokoyama, and H Nakano, and M Kuwabara, and M Yamakido, and H Suginaka

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001398 Aztreonam A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms. Az-threonam,Azactam,Azthreonam,SQ-26,776,Urobactam,Az threonam,SQ 26,776,SQ26,776

Related Publications

Y Miyake, and T Yokoyama, and H Nakano, and M Kuwabara, and M Yamakido, and H Suginaka
Belgian multicenter study on the in vitro activity of aztreonam against gram-negative bacilli.
January 1988, Acta clinica Belgica,
Y Miyake, and T Yokoyama, and H Nakano, and M Kuwabara, and M Yamakido, and H Suginaka
Comparative activities of three new antibacterial agents with aztreonam against gram-negative bacilli.
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
Y Miyake, and T Yokoyama, and H Nakano, and M Kuwabara, and M Yamakido, and H Suginaka
Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
January 1989, Chemotherapy,
Y Miyake, and T Yokoyama, and H Nakano, and M Kuwabara, and M Yamakido, and H Suginaka
Comparative in-vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
July 1989, Journal of chemotherapy (Florence, Italy),
Y Miyake, and T Yokoyama, and H Nakano, and M Kuwabara, and M Yamakido, and H Suginaka
Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli.
August 1983, Antimicrobial agents and chemotherapy,
Y Miyake, and T Yokoyama, and H Nakano, and M Kuwabara, and M Yamakido, and H Suginaka
In vitro activity of carbenicillin against gram-negative bacilli.
May 1968, Journal of bacteriology,
Y Miyake, and T Yokoyama, and H Nakano, and M Kuwabara, and M Yamakido, and H Suginaka
In vitro activity of carbenicillin against gram-negative bacilli.
January 1968, Antimicrobial agents and chemotherapy,
Y Miyake, and T Yokoyama, and H Nakano, and M Kuwabara, and M Yamakido, and H Suginaka
In-vitro activity of aztreonam in combination with four other antibiotics against gram-negative bacilli and Staphylococcus aureus.
April 1984, The Journal of antimicrobial chemotherapy,
Y Miyake, and T Yokoyama, and H Nakano, and M Kuwabara, and M Yamakido, and H Suginaka
Enhanced liposome-mediated antibacterial activity of piperacillin and gentamicin against gram-negative bacilli in vitro.
January 1988, Journal of microencapsulation,
Y Miyake, and T Yokoyama, and H Nakano, and M Kuwabara, and M Yamakido, and H Suginaka
[In vitro activity of aztreonam, cefoperazone and ceftriaxone against gram-negative bacteria].
July 1990, Mikrobiyoloji bulteni,
Copied contents to your clipboard!